Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Abstract Background Methyltransferase-like 3 (METTL3) is a member of the m6A methyltransferase family and acts as an oncogene in cancers. Recent studies suggest that host innate immunity is regulated by the enzymes controlling m6A epitranscriptomic changes. Here, we aim to explore the associations b...
Main Authors: | Huan-he Ni, Lin Zhang, He Huang, Shu-qin Dai, Jiang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02553-z |
Similar Items
-
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
by: Ruyi Li, et al.
Published: (2021-09-01) -
Prognostic Values of METTL3 and Its Roles in Tumor Immune Microenvironment in Pan-Cancer
by: Yang Guo, et al.
Published: (2022-12-01) -
Study on the Value of DCE-MRI in Differentiating Glossitis and Tongue Cancer and the Intratumour Heterogeneity
by: Liu F, et al.
Published: (2021-09-01) -
CD33 as a leukocyte-associated marker expressed on human spermatozoa
by: Nasrin Sereshki, et al.
Published: (2023-04-01) -
Integrative analysis of m3C associated genes reveals METTL2A as a potential oncogene in breast Cancer
by: Shuai Wang, et al.
Published: (2022-10-01)